CRIS Curis, Inc. - Common Stock

NASDAQ · Biotechnology · View on SEC EDGAR ↗
$1.71
Price · Aug 19, 2026
Fundamentals as of Aug 14, 2026

CRIS Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$1.71
Market Cap
$1M
P/E (TTM)
-0.1
EPS (TTM)
$-0.58
Revenue (TTM)
$9M
Div Yield
ROE
177.9%
Debt/Equity
0.0
52W Range
$0 – $9

CRIS Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income $9M
10-point trend, +25.5%
2016-12-31 2025-12-31
EPS $-0.58
7-point trend, +40.2%
2019-12-31 2025-12-31
Free Cash Flow
7-point trend, -6.3%
2016-12-31 2023-12-31
Margins -80.3%

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
CRIS
Peer Median
P/E (TTM)
5-point trend, -100.9%
-0.1
P/S (TTM)
5-point trend, -99.9%
0.1
2.9
P/B
5-point trend, -98.0%
0.2
1.1
EV / EBITDA
5-point trend, +97.0%
0.7

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
CRIS
Peer Median
Operating Margin
5-point trend, +73.7%
-60.5%
Net Profit Margin
5-point trend, +70.9%
-80.3%
-4409.1%
ROA
5-point trend, +0.8%
-24.8%
-111.4%
ROE
5-point trend, +403.5%
177.9%
-169.4%

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
CRIS
Peer Median
Debt / Equity
5-point trend, +0.00
0.0
0.0
Current Ratio
5-point trend, -97.1%
0.5
1.9
Quick Ratio
5-point trend, -97.9%
0.4

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
CRIS
Peer Median
Revenue YoY
5-point trend, -11.3%
-13.4%
Revenue CAGR 3Y
5-point trend, -11.3%
-2.4%
Revenue CAGR 5Y
5-point trend, -11.3%
-2.7%

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
CRIS
Peer Median
EPS (Diluted)
5-point trend, -216.0%
$-0.58

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
CRIS
Peer Median

CRIS Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 10 analysts
  • Strong Buy 2 20.0%
  • Buy 7 70.0%
  • Hold 1 10.0%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

3 analysts · 2026-08-16
Median target $43.00 +2420.8%
Mean target $42.67 +2401.3%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-1.8%
Period EPS Actual EPS Est Surprise
March 31, 2026 $-25.00 $-8.16 -16.8%
Dec. 31, 2025 $-10.00 $-9.18 -0.82%
Sept. 30, 2025 $-9.80 $-11.79 2.0%
June 30, 2025 $-13.60 $-18.16 4.6%
March 31, 2025 $-1.25 $-1.21 -0.04%
Dec. 31, 2024 $-1.25 $-1.39 0.14%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
CRIS $13M -1.7 -13.4% -80.3% 177.9%
HCWB -0.1 -97.9% -14677.1% -586.8% 20.0%
REVB
SILO $5M -0.7 0.00% -5863.5% -75.3% 38.6%
VIVS $4M -0.3 -9.0% -10567.2% -294.8%
RNAZ -0.1
ONCO $2M -0.1 -67.7% -1721.0% -129.5% 77.6%
BIAF

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

Income Statement 15
Annual Income Statement data for CRIS
Metric Trend 202520242023202220212020201920182017201620152014
Revenue 12-point trend, -4.1% $9M $11M $10M $10M $11M $11M $10M $10M $10M $8M $8M $10M
R&D Expense 2-point trend, +31.8% · · · · · · · · · $18M · $14M
SG&A Expense 12-point trend, +20.0% $14M $17M $19M $20M $17M $12M $12M $15M $14M $16M $13M $12M
Operating Expenses 12-point trend, +64.7% $42M $55M $58M $63M $53M $36M $34M $40M $60M $66M $64M $26M
Operating Income 12-point trend, +64.0% $-6M $-45M $-48M $-53M $-42M $-25M $-24M $-29M $-50M $-58M $-56M $-16M
Interest Expense 8-point trend, -100.0% · · · · $0 $0 $791.0K $4M $4M $3M $3M $4M
Interest Income 12-point trend, +91.5% $316.0K $2M $3M $1M $211.0K $63.0K $614.0K $684.0K $513.0K $406.0K $277.0K $165.0K
Other Non-op 12-point trend, +34.8% $-2M $1M $919.0K $-4M $890.0K $22.0K $-58.0K $0 $-4M $-2M $-2M $-3M
Income Tax Flat — no change across 2 periods $0 $0 · · · · · · · · · ·
Net Income 12-point trend, +59.5% $-8M $-43M $-47M $-57M $-45M $-30M $-32M $-33M $-53M $-60M $-59M $-19M
EPS (Basic) 7-point trend, +40.2% $-0.58 $-6.88 $-8.96 $-12.14 $0.50 $-0.61 $-0.97 · · · · ·
EPS (Diluted) 7-point trend, +40.2% $-0.58 $-6.88 $-8.96 $-12.14 $0.50 $-0.61 $-0.97 · · · · ·
Shares (Basic) 7-point trend, -60.3% 13,164,032 6,306,284 5,293,294 4,669,626 91,569,154 48,670,381 33,180,516 · · · · ·
Shares (Diluted) 7-point trend, -60.3% 13,164,032 6,306,284 5,293,294 4,669,626 91,569,154 48,670,381 33,180,516 · · · · ·
EBITDA 11-point trend, +64.0% $-6M $-45M $-48M · $-42M $-25M $-24M $-29M $-50M $-58M $-56M $-16M
Balance Sheet 27
Annual Balance Sheet data for CRIS
Metric Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, -34.7% $5M $20M $27M $20M $40M $130M $15M $24M $38M $26M $33M $8M
Short-term Investments 11-point trend, -100.0% · $0 $30M $66M $76M $39M $5M $634.0K $22M $18M $49M $42M
Receivables 12-point trend, -100.0% $0 $3M $3M $3M $3M $3M $3M $3M $3M $2M $2M $2M
Prepaid Expense 12-point trend, +278.5% $2M $3M $2M $4M $3M $1M $1M $827.0K $989.0K $1M $1M $489.8K
Current Assets 12-point trend, -86.8% $7M $26M $61M $92M $122M $173M $25M $28M $64M $48M $86M $52M
PP&E (Net) 12-point trend, -84.8% $62.0K $231.0K $434.0K $689.0K $505.0K $663.0K $154.0K $267.0K $400.0K $400.0K $300.0K $407.7K
PP&E (Gross) 12-point trend, -60.9% $913.0K $1M $2M $3M $3M $3M $2M $2M $2M $2M $2M $2M
Accum. Depreciation 12-point trend, -55.9% $851.0K $1M $2M $2M $2M $2M $2M $2M $2M $2M $2M $2M
Goodwill 12-point trend, +0.0% $9M $9M $9M $9M $9M $9M $9M $9M $9M $9M $9M $9M
Other Non-current Assets 12-point trend, +2228.9% $2M $2M $3M $2M $0 $3.0K $3.0K $2.0K $3.0K $3.0K $51.0K $67.5K
Total Assets 12-point trend, -68.1% $20M $41M $77M $109M $162M $204M $35M $37M $74M $58M $95M $63M
Accounts Payable 12-point trend, +138.9% $6M $3M $3M $3M $6M $4M $4M $3M $5M $6M $4M $2M
Accrued Liabilities 12-point trend, +262.3% $7M $7M $9M $6M $6M $4M $2M $3M $3M $3M $2M $2M
Current Liabilities 12-point trend, +39.8% $14M $19M $22M $10M $13M $10M $7M $13M $14M $14M $11M $10M
Capital Leases 7-point trend, +428000.00 $428.0K $2M $1M $3M $4M $5M $0 · · · · ·
Other Non-current Liabilities 8-point trend, -100.0% · · · · $0 $334.0K $0 $11.0K $34.0K $18.0K $139.0K $174.0K
Total Liabilities 12-point trend, -55.8% $15M $47M $58M $62M $72M $74M $69M $42M $50M $28M $30M $33M
Long-term Debt 7-point trend, -96.9% · · · · · $891.0K $0 $35M $42M $20M $24M $28M
Total Debt 10-point trend, -100.0% $0 $8M · · $0 $557.0K $0 $35M $42M $20M $24M $28M
Common Stock 12-point trend, -99.3% $6.0K $85.0K $59.0K $48.0K $916.0K $915.0K $332.0K $332.0K $331.0K $1M $1M $872.5K
Paid-in Capital · · · · · · · · · · · $810M
Retained Earnings 12-point trend, -60.0% $-1.25B $-1.24B $-1.20B $-1.15B $-1.09B $-1.05B $-1.02B $-985M $-952M $-899M $-839M $-780M
Treasury Stock 5-point trend, -100.0% · · · · · · · $0 $2M $2M $2M $2M
AOCI 11-point trend, +100.0% · $0 $229.0K $-186.0K $-109.0K $-3.0K $0 $0 $-2.0K $-4.0K $28.0K $-11.0K
Stockholders' Equity 12-point trend, -81.7% $5M $-6M $20M $47M $91M $131M $-34M $-4M $24M $29M $65M $30M
Liabilities + Equity 12-point trend, -68.1% $20M $41M $77M $109M $162M $204M $35M $37M $74M $58M $95M $63M
Shares Outstanding 12-point trend, -99.2% 646,537 8,487,818 5,894,085 4,830,464 91,645,369 91,502,461 33,241,793 33,159,253 32,831,380 141,124,025 128,990,378 86,030,811
Cash Flow 10
Annual Cash Flow data for CRIS
Metric Trend 202520242023202220212020201920182017201620152014
D&A 12-point trend, -15.5% $169.0K $203.0K $255.0K $233.0K $158.0K $144.0K $125.0K $177.0K $235.0K $193.0K $200.0K $200.0K
Stock-based Comp 12-point trend, +31.3% $4M $6M $6M $7M $5M $3M $3M $4M $5M $4M $4M $3M
Operating Cash Flow 12-point trend, -61.8% $-27M $-40M $-38M $-54M $-38M $-26M $-26M $-30M $-48M $-36M $-30M $-17M
CapEx 10-point trend, -100.0% · · $0 $416.0K $0 $677.0K $41.0K $85.0K $188.0K $329.0K $48.0K $92.0K
Investing Cash Flow 12-point trend, -84.6% $2M $29M $38M $33M $-48M $-49M $-4M $21M $-4M $30M $-6M $16M
Stock Issued 12-point trend, +15352000.00 $15M $12M $14M $6M $0 $159M $0 $0 $42M $0 $65M $0
Net Stock Activity 10-point trend, +5328.6% $15M $12M $14M · $0 $159M · $0 $42M $0 $65M $282.8K
Financing Cash Flow 12-point trend, +848.8% $10M $3M $8M $867.0K $-4M $189M $23M $-6M $64M $-1M $62M $-1M
Net Change in Cash 12-point trend, -710.0% $-15M $-7M $7M $-20M $-90M $114M $-7M $-15M $12M $-7M $25M $-2M
Free Cash Flow 9-point trend, -127.4% · · $-38M · $-38M $-26M $-26M $-30M $-49M $-36M $-30M $-17M
Profitability 5
Annual Profitability data for CRIS
Metric Trend 202520242023202220212020201920182017201620152014
Operating Margin 11-point trend, +62.5% -60.5% -408.3% -482.2% · -395.0% -229.8% -243.5% -281.3% -502.7% -771.1% -716.9% -161.1%
Net Margin 11-point trend, +57.8% -80.3% -397.8% -473.0% · -426.7% -276.0% -320.9% -312.6% -538.7% -802.6% -748.6% -190.3%
EBITDA Margin 11-point trend, +62.5% -60.5% -408.3% -482.2% · -395.0% -229.8% -243.5% -281.3% -502.7% -771.1% -716.9% -161.1%
ROA 11-point trend, +5.3% -24.8% -73.2% -50.9% · -24.8% -25.0% -88.6% -58.7% -81.1% -79.1% -74.9% -26.2%
ROE 11-point trend, +456.0% 177.9% 589.0% -192.5% · -46.9% -58.6% 107.1% 1755.5% -199.5% -128.8% -125.1% -50.0%
Liquidity & Solvency 5
Annual Liquidity & Solvency data for CRIS
Metric Trend 202520242023202220212020201920182017201620152014
Current Ratio 11-point trend, -90.5% 0.5 1.4 4.5 · 9.1 17.1 3.8 2.1 4.6 3.6 7.9 5.2
Quick Ratio 11-point trend, -93.0% 0.4 1.2 4.4 · 8.9 17.0 3.6 2.0 4.5 3.5 7.8 5.1
Debt / Equity 10-point trend, -100.0% 0.0 -1.3 · · 0.0 0.0 0.0 -7.9 1.7 0.7 0.4 1.0
LT Debt / Equity 6-point trend, -100.0% · · · · · · 0.0 -6.4 1.5 0.5 0.3 0.8
Interest Coverage 6-point trend, -627.6% · · · · · · -30.8 -7.5 -12.5 -20.9 -17.0 -4.2
Efficiency 2
Annual Efficiency data for CRIS
Metric Trend 202520242023202220212020201920182017201620152014
Asset Turnover 11-point trend, +124.3% 0.3 0.2 0.1 · 0.1 0.1 0.3 0.2 0.2 0.1 0.1 0.1
Receivables Turnover 11-point trend, -1.5% 5.6 3.6 3.5 · 3.4 3.4 3.3 3.5 3.6 3.3 3.9 5.7
Per Share 5
Annual Per Share data for CRIS
Metric Trend 202520242023202220212020201920182017201620152014
Book Value / Share 11-point trend, +22.0% $0.42 $-0.71 $3.34 · $0.99 $1.43 $-1.02 $-0.14 $0.15 $0.21 $0.50 $0.35
Revenue / Share 4-point trend, +516.8% $0.72 $1.73 $1.89 · $0.12 · · · · · · ·
Cash Flow / Share 4-point trend, -403.0% $-2.07 $-6.27 $-7.26 · $-0.41 · · · · · · ·
Cash / Share 11-point trend, +334.5% $0.39 $2.36 $4.53 · $0.44 $1.42 $0.46 $0.71 $0.23 $0.18 $0.26 $0.09
EPS (TTM) 7-point trend, +40.2% $-0.58 $-6.88 $-8.96 $-12.14 $0.50 $-0.61 $-0.97 · · · · ·
Growth Rates 3
Annual Growth Rates data for CRIS
Metric Trend 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -680.8% -13.4% 8.8% -1.4% -4.6% -1.7% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +5.5% -2.4% 0.80% -2.6% · · · · · · · · ·
Revenue CAGR 5Y -2.7% · · · · · · · · · · ·
Valuation (TTM) 14
Annual Valuation (TTM) data for CRIS
Metric Trend 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, -4.1% $9M $11M $10M $10M $11M $11M $10M $10M $10M $8M $8M $10M
Net Income TTM 12-point trend, +59.5% $-8M $-43M $-47M $-57M $-45M $-30M $-32M $-33M $-53M $-60M $-59M $-19M
Market Cap 11-point trend, -99.9% $13M $26M $75M · $8.72B $14.99B $1.13B $458M $11.49B $43.47B $37.54B $12.90B
Enterprise Value 10-point trend, -99.9% $8M $14M · · $8.61B $14.82B $1.11B $469M $11.47B $43.44B $37.48B $12.88B
P/E 7-point trend, +95.1% -1.7 -0.4 -1.4 -0.9 190.4 -268.5 -35.1 · · · · ·
P/S 11-point trend, -99.9% 1.4 2.4 7.5 · 819.3 1383.3 113.0 43.9 1160.9 5774.7 4764.7 1311.0
P/B 11-point trend, -99.5% 2.3 -4.3 3.8 · 96.2 114.7 -33.3 -101.8 478.9 1485.2 581.9 433.3
P / Tangible Book 4-point trend, -94.3% · · 7.0 28.3 106.8 123.2 · · · · · ·
P / Cash Flow 11-point trend, +99.9% -0.5 -0.7 -2.0 · -231.9 -582.3 -43.1 -15.2 -237.6 -1213.8 -1255.8 -767.5
P / FCF 9-point trend, +99.7% · · -2.0 · -231.9 -567.4 -43.1 -15.2 -236.7 -1202.7 -1253.8 -763.4
EV / EBITDA 10-point trend, +99.8% -1.4 -0.3 · · -204.7 -595.2 -45.6 -16.0 -230.6 -748.5 -663.6 -812.2
EV / FCF 8-point trend, +70.0% · · · · -228.8 -561.0 -42.3 -15.5 -236.3 -1202.0 -1251.8 -762.1
EV / Revenue 10-point trend, -99.9% 0.8 1.2 · · 808.4 1367.8 110.9 45.0 1159.1 5771.4 4757.3 1308.9
Earnings Yield 7-point trend, -1955.8% -58.6% -224.8% -70.3% -110.4% 0.53% -0.37% -2.9% · · · · ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

Income Statement
2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $9M$11M$10M$10M$11M
Operating Margin % -60.5%-408.3%-482.2%-395.0%
Net Income $-8M$-43M$-47M$-57M$-45M
Diluted EPS $-0.58$-6.88$-8.96$-12.14$0.50
Balance Sheet
2025-12-312024-12-312023-12-312022-12-312021-12-31
Debt / Equity 0.0-1.30.0
Current Ratio 0.51.44.59.1
Quick Ratio 0.41.24.48.9
Cash Flow
2025-12-312024-12-312023-12-312022-12-312021-12-31
Free Cash Flow $-38M$-38M

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 39 filers · $7.0M total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
9 (+1 vs prior Q) 12 (+4 vs prior Q) 5 (-8 vs prior Q) 7 (+1 vs prior Q) -3.9M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Bleichroeder LP $1,985,196 3,802,329 28.49% Shares
Stonepine Capital Management, LLC $1,729,292 3,312,185 24.82% Shares
SPHERA FUNDS MANAGEMENT LTD. $1,033,717 98,996 14.84% Shares
Cable Car Capital, LP $696,134 1,333,334 9.99% Shares
CM Management, LLC $287,155 550,000 4.12% Shares
MORGAN STANLEY $263,290 504,291 3.78% Shares
VANGUARD CAPITAL MANAGEMENT LLC $179,486 343,842 2.58% Shares
M28 Capital Management LP $148,741 284,889 2.13% Shares
GEODE CAPITAL MANAGEMENT, LLC $142,044 272,044 2.04% Shares
FLPUTNAM INVESTMENT MANAGEMENT CO $128,306 245,750 1.84% Shares
RENAISSANCE TECHNOLOGIES LLC $74,123 141,972 1.06% Shares
VANGUARD GROUP INC $60,862 61,664 0.87% Shares
XTX Topco Ltd $56,470 108,160 0.81% Shares
NORTHERN TRUST CORP $50,054 95,870 0.72% Shares
VANGUARD FIDUCIARY TRUST CO $32,189 61,664 0.46% Shares
BlackRock, Inc. $27,846 53,334 0.40% Shares
Focused Wealth Management, Inc $26,131 50,049 0.38% Shares
STATE STREET CORP $10,990 21,049 0.16% Shares
FRANKLIN STREET ADVISORS INC /NC $10,442 20,000 0.15% Shares
LPL Financial LLC $7,819 14,977 0.11% Shares
MAVERICK CAPITAL LTD $6,194 49,554 0.09% Shares
Dauntless Investment Group, LLC $5,222 10,001 0.07% Shares
BARCLAYS PLC $3,641 6,973 0.05% Shares
Steward Partners Investment Advisory, LLC $1,356 2,597 0.02% Shares
OSAIC HOLDINGS, INC. $785 1,510 0.01% Shares
GROUP ONE TRADING LLC $235 450 0.00% Shares
Axiom Investment Management LLC $52 100 0.00% Shares
JPMORGAN CHASE & CO $48 108 0.00% Shares
JONES FINANCIAL COMPANIES LLLP $39 120 0.00% Shares
WELLS FARGO & COMPANY/MN $29 55 0.00% Shares
CWM, LLC $28 51 0.00% Shares
UBS Group AG $16 31 0.00% Shares
GSA CAPITAL PARTNERS LLP $12 22,760 0.00% Shares
CIBC Private Wealth Group LLC $10 6 0.00% Shares
WR Wealth Planners, LLC $3 1 0.00% Shares
Blue Trust, Inc. $2 4 0.00% Shares
VIMA LLC $2 3 0.00% Shares
MPWM ADVISORY SOLUTIONS, LLC $1 2 0.00% Shares
ROYAL BANK OF CANADA $0 63 0.00% Shares

Company insiders 33 insiders · 17 officers · 16 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
James E Dentzer President & CEO July 7, 2026 A 148,730 0 0 $0
Ali Fattaey Ph.D. President & CEO May 15, 2018 A 322,140 0 0 $0
Diantha Duvall CFO July 7, 2026 A 77,707 0 0 $0
William Steinkrauss Chief Financial Officer Jan. 29, 2022 A 0 0 $0
Michael Gray CFO May 27, 2015 A 107,304 0 0 $0
Mitchell Keegan Vice-President Jan. 7, 2011 A 0 0 $0
Jonathan B. Zung CDO July 7, 2026 A 66,667 0 0 $0
Ahmed Hamdy MD CMO March 20, 2026 C 66,667 0 0 $0
Robert Martell Head of Research & Development Jan. 20, 2023 A 23,027 0 0 $0
David Tuck Chief Medical Officer May 15, 2018 A 169,424 0 0 $0
Mani Mohindru Chief Strategy Officer Feb. 14, 2017 A 0 0 $0
Jaye Viner Chief Medical Officer May 27, 2015 A 0 0 $0
Mark Noel VP, Tech Management May 2, 2013 M 27,540 0 0 $0
Changgeng Qian VP, Research & Preclinical Dev Jan. 7, 2011 A 0 0 $0
Mary Elizabeth Potthoff VP and General Counsel May 31, 2006 A 0 0 0 $0
Lee L Rubin VP of Research June 1, 2005 A 9,814 0 0 $0
Christopher U Missling Sr. VP, Strategic Planning Jan. 16, 2004 M 0 0 0 $0
Anne Elizabeth Borgman Director July 7, 2026 A 0 0 $0
John Hohneker Director July 7, 2026 A 0 0 $0
Marc Rubin Director July 7, 2026 A 28,108 0 0 $0
Kenneth I Kaitin Director July 7, 2026 A 11,407 1 0 $5,500
Martyn D Greenacre Director July 7, 2026 A 26,089 0 0 $0
Lori Anne Kunkel Director Jan. 31, 2022 A 22,200 0 0 $0
James R Mcnab Director May 5, 2017 S 50,000 0 0 $0
Kenneth Pienta Director Feb. 28, 2017 A 30,000 0 0 $0
James R Tobin Director Jan. 26, 2015 A 144,921 0 0 $0
Susan B Bayh Director Jan. 17, 2013 A 25,000 0 0 $0
Joseph Davie MD PHD Director Jan. 7, 2011 A 0 0 $0
Stephen Carter Director Jan. 25, 2008 A 0 0 $0
Joseph M Davie Director June 6, 2007 A 20,000 0 0 $0
Douglas Melton Director Aug. 23, 2006 A 173,499 0 0 $0
Daniel R Passeri Jan. 19, 2016 A 211,798 0 0 $0
Maurizio Voi Jan. 17, 2013 A 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

Activists & 5%+ owners 3 positions

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Undisclosed reporting person March 4, 2004 Initial filing SEC
Undisclosed reporting person Jan. 29, 2004 Initial filing Passive investment SEC
Undisclosed reporting person June 4, 2003 Initial filing SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 2 ETFs

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
VXF · VANGUARD INDEX FUNDS 0.00% 128,243 SH Aug. 8, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.00% 215,599 SH Aug. 8, 2026 Daily